Annual EBITDA
Summary
- Current Value
- As of today, RDY annual EBITDA is $1.02B, up +7.69% on
- Historical Performance
- RDY annual EBITDA is up +64.73% over the past 3 years, and up +76.59% over the past 5 years
- All-Time High Comparison
- RDY annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- RDY annual EBITDA is +64.73% above its 3-year low of $621.49M reached on an earlier date
- Sector Comparison
- RDY annual EBITDA is higher than 94.34% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.02B | +7.7% | +64.7% | +76.6% | +235.8% | |
| Quarterly EBITDA | $213.48M | – | -15.0% | +39.4% | +152.7% | |
| TTM EBITDA | $939.01M | – | +22.8% | +57.9% | +202.1% | |
| Price | $14.00 | +0.2% | +31.9% | +6.7% | +101.5% | |
| PE Ratio | 17.97 | -1.1% | -7.1% | -52.7% | -41.6% | |
| Annual Revenue | $3.85B | +14.2% | +33.8% | +56.4% | +158.6% | |
| Annual EPS | $0.80 | -0.6% | +110.8% | +142.1% | +815.2% | |
| $822.04M | +6.6% | +77.6% | +103.5% | +278.1% | ||
| Annual Net Income | $677.08M | +0.7% | +114.1% | +146.2% | +809.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.02B | at high | |
| 5Y | $1.02B | at high | |
| All | $1.02B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $621.49M | N/A | +64.7% |
| 5Y | $579.77M | N/A | +76.6% |
| All | $11.77M | +8595.2% |
EBITDA History
FAQ
What is the current annual EBITDA of RDY?
As of today, RDY annual EBITDA is $1.02B
What is 1-year change in RDY annual EBITDA?
RDY annual EBITDA is up +7.69% year-over-year
What is 3-year change in RDY annual EBITDA?
RDY annual EBITDA is up +64.73% over the past 3 years
How far is RDY annual EBITDA from its all-time high?
RDY annual EBITDA is currently at its all-time high
How does RDY annual EBITDA rank versus sector peers?
RDY annual EBITDA is higher than 94.34% of companies in Healthcare sector
When is RDY next annual earnings release?
The next annual earnings release for RDY is on
Quarterly EBITDA
Summary
- Current Value
- As of today, RDY quarterly EBITDA is $213.48M, down -9.68% on
- Historical Performance
- RDY quarterly EBITDA 1-year change is unknown, and down -14.99% over the past 3 years
- All-Time High Comparison
- RDY quarterly EBITDA is currently -16.99% below its historical high of $257.18M set on
- 3-Year Low Comparison
- RDY quarterly EBITDA is +10.92% above its 3-year low of $192.46M reached on
- Sector Comparison
- RDY quarterly EBITDA is higher than 92.68% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $213.48M | -9.7% | – | -15.0% | +39.4% | |
| Annual EBITDA | $1.02B | – | +7.7% | +64.7% | +76.6% | |
| TTM EBITDA | $939.01M | +29.4% | – | +22.8% | +57.9% | |
| Price | $14.00 | +4.5% | +0.2% | +31.9% | +6.7% | |
| PE Ratio | 17.97 | +9.5% | -1.1% | -7.1% | -52.7% | |
| Quarterly Revenue | $979.53M | -2.9% | -1.0% | +19.0% | +46.6% | |
| Quarterly EPS | $0.16 | -17.5% | -18.9% | -10.8% | +4984.4% | |
| $154.94M | -13.2% | -25.0% | -26.7% | +41.4% | ||
| Quarterly Net Income | $133.53M | -18.3% | -19.7% | -12.0% | +4876.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $252.46M | -15.4% | |
| 3Y | $257.18M | -17.0% | |
| 5Y | $257.18M | -17.0% | |
| All | $257.18M | -17.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $213.48M | at low | |
| 3Y | $192.46M | +10.9% | |
| 5Y | $120.61M | +77.0% | |
| All | $1.46M | >+9999.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RDY?
As of today, RDY quarterly EBITDA is $213.48M
What is RDY quarterly EBITDA most recent change?
RDY quarterly EBITDA was down -9.68% on December 31, 2025
What is 1-year change in RDY quarterly EBITDA?
RDY quarterly EBITDA 1-year change is unknown
How far is RDY quarterly EBITDA from its all-time high?
RDY quarterly EBITDA is currently -16.99% below its historical high of $257.18M set on September 30, 2024
How does RDY quarterly EBITDA rank versus sector peers?
RDY quarterly EBITDA is higher than 92.68% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
TTM EBITDA
Summary
- Current Value
- As of today, RDY TTM EBITDA is $939.01M, up +29.42% on
- Historical Performance
- RDY TTM EBITDA 1-year change is unknown, and up +22.81% over the past 3 years
- All-Time High Comparison
- RDY TTM EBITDA is currently -3.33% below its historical high of $971.34M set on
- 3-Year Low Comparison
- RDY TTM EBITDA is +29.42% above its 3-year low of $725.53M reached on
- Sector Comparison
- RDY TTM EBITDA is higher than 93.50% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $939.01M | +29.4% | – | +22.8% | +57.9% | |
| Annual EBITDA | $1.02B | – | +7.7% | +64.7% | +76.6% | |
| Quarterly EBITDA | $213.48M | -9.7% | – | -15.0% | +39.4% | |
| Price | $14.00 | +4.5% | +0.2% | +31.9% | +6.7% | |
| PE Ratio | 17.97 | +9.5% | -1.1% | -7.1% | -52.7% | |
| TTM Revenue | $3.97B | -0.3% | +6.7% | +31.8% | +57.5% | |
| TTM EPS | $0.78 | -4.6% | +1.3% | +41.9% | +125.6% | |
| $714.37M | -6.7% | -10.3% | +17.7% | +68.2% | ||
| TTM Net Income | $644.85M | -4.8% | -0.9% | +41.2% | +124.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $939.01M | at high | |
| 3Y | $971.34M | -3.3% | |
| 5Y | $971.34M | -3.3% | |
| All | $971.34M | -3.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $725.53M | +29.4% | |
| 3Y | $725.53M | +29.4% | |
| 5Y | $579.16M | +62.1% | |
| All | $15.84M | +5826.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RDY?
As of today, RDY TTM EBITDA is $939.01M
What is RDY TTM EBITDA most recent change?
RDY TTM EBITDA was up +29.42% on December 31, 2025
What is 1-year change in RDY TTM EBITDA?
RDY TTM EBITDA 1-year change is unknown
How far is RDY TTM EBITDA from its all-time high?
RDY TTM EBITDA is currently -3.33% below its historical high of $971.34M set on September 30, 2024
How does RDY TTM EBITDA rank versus sector peers?
RDY TTM EBITDA is higher than 93.50% of companies in Healthcare sector
When is RDY next earnings release?
The next earnings release for RDY is on
EBITDA Formula
Data Sources & References
- RDY Official Website www.drreddys.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1135951/000157587226000031/0001575872-26-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1135951/000157587225000393/0001575872-25-000393-index.htm
- RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
- RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy
